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Background: Melatonin inclusion into in vitro oocyte maturation (IVM) protocols has been suggested because it
possesses a powerful free radical scavenger capability that improves the quality of the oocyte used in in vitro
embryo production (IVP). The aim of our study was to investigate the presence of melatonin membrane receptors
(MT1and MT2) and MT3, which is the melatonin binding site of NQO2 enzyme, in both oocytes and hatched
blastocysts to consider an additional subcellular mechanism responsible for the effects of melatonin on IVP.
Methods: The presence of the high affinity melatonin receptors was investigated through an autoradiographic
binding assay, using the non-permeable ligand [125I]-iodomelatonin (17 pM) in embryos. The kind of melatonin site
was investigated in oocytes and embryos by immunocytochemistry. In vitro fertilized bovine embryos produced
from in vitro maturated oocytes supplemented with melatonin (0.0001 to 1000 nM) were analysed to determine
their cleavage and blastocyst formation rates.
Results: The [125I]-iodomelatonin (17 pM) binding in blastocysts was blocked by pre-incubation with melatonin
(30000 nM), showing the presence of the high affinity melatonin receptors. MT1, MT2 and NQO2 immunoreactivity
was observed in oocytes. MT1 immunoreactivity was observed in hatched blastocysts, however MT2 and NQO2
were not observed in this embryonic stage. Melatonin (pM) triggered significant difference in both cleavage and
blastocysts formation rates.
Conclusions: The high affinity MT1 melatonin receptor must be taking part in IVM events; furthermore it is the first
melatonin receptor to appear during bovine embryo development in vitro.
Keywords: Melatonin, Antioxidant, MT1 melatonin receptor, MT2 melatonin receptor, NQO2, Mechanisms of
developmentBackground
Environmental lighting controls temporal changes for
organisms that live on earth. In mammals, the major
biological clock is located in the suprachiasmatic nucleus
(SCN). This major clock drives other minor biological
clocks that are located in the peripheral tissues. In the* Correspondence: lsampaio@ufpa.br
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reproduction in any medium, provided the ordark phase of the circadian rhythm, the SCN signals the
pineal gland to release indoleamine melatonin (N-acetyl-5
methoxytriptamine). During pregnancy, maternal mela-
tonin crosses the placenta, signalling the day length for
the fetus, and modulates fetal development [1-4].
In development, melatonin acts by means of the MT1
and MT2 membrane receptors (Mel1a and Mel1b for
avian), mainly by inhibiting the adenylate cyclase enzyme
[3]. Due to the lipophilic nature of melatonin, it is able
to function by binding to receptor in the nucleus [5], a
cytosolic binding site the calmodulin protein [6] and alsoal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Quinone Oxireductase 2 (NQO2). It does so through the
MT3 melatonin binding site, which was showed to be
NQO2 [7]. Furthermore, it has been observed that mela-
tonin modulates the myeloperoxidase enzyme [8]. How-
ever, the most primitive mechanism of melatonin action
is the direct scavenger function on reactive oxygen spe-
cies (ROS), such as hydrogen peroxide (H2O2) and the
super-oxide anion (O2
-). This neurohormone also has an
indirect antioxidant role thought to be triggered by
membrane receptors and binding sites, mainly resulting
in the up regulation of the antioxidant enzymes (gluta-
thione peroxidase, glutathione reductase, gamma-
glutamyl cisteine synthetase and glucose 6-phosphate
deydrogenase) and the down regulation of the oxidant
enzymes (NO synthase and lipoxygenases) [9,10].
Furthermore, melatonin modulates mammalian
reproduction [11,12]. In the ovary, this hormone pro-
tects and stimulates folliculogenesis [13]. Its synthesis
takes place in both cumulus cells and oocytes, where it
reaches high levels. In fact, ovarian follicular fluid con-
tains melatonin in higher concentrations than in plasma.
At these concentrations, melatonin has a protective ac-
tion by acting as a direct free radical scavenger [14,15].
Additionally, several effects of melatonin on the ovary
are triggered by its membrane receptors that are also
underlying its effects on photoperiodism, and on other
events related to reproduction [16-21].
The direct free radical scavenger action of melatonin
is very useful to the development of an embryo pro-
duced in vitro. It is important to note that species-
specific concentration of the melatonin included in
oocyte in vitro maturation (IVM) protocols increases the
production of in vitro fertilized embryos in mice [22,23],
pig [24] and buffalo [25]. The addition of melatonin is
very useful as a sperm cryoprotective agent as well [26].
The addition of melatonin in IVM medium is justified
because in vitro production (IVP) is strongly influenced
by events before in vitro fertilization (IVF), particularly
during IVM [27,28]. The maturation process is where
the oocyte acquires “competence” to assure proper zyg-
otic development until the blastocyst stage [29]. It has
been showed that melatonin has a long-term effect on
embryos, which is observed in cleavage and blastocysts
formation rates. The efficacy of melatonin depends on
culture conditions, such as O2 tension [30]. This de-
pendence of the O2 tension further suggests that mela-
tonin influences in vitro embryogenesis by acting as a
radical free scavenger. Others constituents of the IVM
culture medium (i.e. FSH and LH) [31] can also influ-
ence the melatonin efficacy on oocyte maturation as
well. Beside animal reproduction, melatonin has been
used in human assisted reproductive technologies. To
increase fertilization and pregnancy rates for femaleinfertility due to poor oocyte quality, oocytes are treated
with melatonin. This results from melatonin reduction
of the toxic products caused by oxidative stress during
oocyte maturation [32].
The aim of the study was to evaluate the effects of
melatonin on bovine oocyte IVM by measuring the
cleavage rates and blastocysts formation rates, as well as
investigating the presence of the NQO2 enzyme, and
MT1 and MT2 melatonin membrane receptors in bo-
vine oocytes and blastocysts.
Methods
In vitro embryo production (IVP)
Institutional approval was received for the work with
embryos in this study (94/2010-ICB). The IVP was per-
formed as previously described [33]. Briefly, bovine ovaries
were obtained from a slaughterhouse and transported to
the laboratory in saline solution (0.9% NaCl). Cumulus-
oocytes complexes (COCs) were recovered from small an-
tral follicles (2–8 mm) by follicular aspiration. Only COCs
with at least three compact cumulus cell layers and homo-
geneous cytoplasm [34] were selected for IVM. Groups of
15 COCs were cultured in a 100 μl droplet of TCM-199
supplemented with sodium bicarbonate, 10% of FBS
(Gibco BRL, Grand Island, NY, USA), 11 mg/ml of pyru-
vate, 50 μg/ml of gentamicin, 0.5 μg/ml of FSH (Folltro-
pin, Bioniche Animal Health Belleville, Ont., Canada), and
5.0 μg/ml of LH (Lutropin, Bioniche Animal Health Belle-
ville, Ont., Canada). The dishes were covered with mineral
oil and incubated for 24 h in a humidified atmosphere of
5% CO2 in air at 38.5°C. Frozen-thawed bull semen (Bos
taurus) was prepared for IVF by density gradient centrifu-
gation in Percoll. Sperm cells were counted in Neubauer
chamber and then added to IVF droplets (2 × 106 sperm-
atozoa/ml). Matured oocytes were washed, transferred to
IVF droplets (80 μl of TALP-FERT medium supplemented
with heparin, penicillin, hypotaurine, epinephrine and
BSA) and incubated in an atmosphere of 5% CO2 in air at
38.5°C. After 24 h of IVF, cumulus cells that were still sur-
rounding the fertilized oocytes were mechanically
removed by successive pipetting. Groups of 20 presump-
tive zygotes were washed and transferred to 100 μl dro-
plets of Synthetic Oviduct Fluid [35] supplemented with
2.5% (v/v) FBS. Embryo development was supported by a
co-culture with a granulosa cell monolayer in an atmos-
phere of 5% CO2 in air at 38.5°C for 7 days.
Melatonin treatment during IVM and embryonic analyses
After selection, pools of 15 COCs were randomly dis-
tributed in seven groups and incubated in droplets of
IVM medium without melatonin (control) or supple-
mented with 0.1 pM, 1 pM, 0.01 nM, 0.1 nM, 1 nM, and
1 μM of melatonin (Sigma Co., St. Louis, MO, USA).
Melatonin was diluted in DMSO plus medium (V/V),
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to 0.1 pM using only IVM medium. The effect of mela-
tonin during IVM was evaluated further in bovine
embryo development after IVF. Cleavage was recorded
at day 2 and blastocyst formation was evaluated at day 7
of IVC (IVF was set as Day 0). Obtained blastocysts were
fixed in a paraformaldehyde solution (3.7%) for 15 min-
utes and then stained with 5 μg/ml of Hoechst 33342
(Sigma Co., St. Louis, MO, USA) for 10 minutes and
visualized by fluorescence microscopy (Nikon Eclipse
TE300). Nuclei were counted from pictures taken from
individual blastocysts. The higher dose of DMSO used
was without effect, comparing with controls non-
melatonin treated.
Autoradiography binding assay
Two pools of six day 7 bovine blastocysts in vitro-pro-
duced from oocytes maturated without melatonin were
incubated in a serum free medium containing the mela-
tonin membrane receptors agonist [125I]-iodomelatonin
(NEN™ Life Sciences Products, Inc. Boston, MA, USA)
(17 pM) for 1 h. The pool used for non-specific binding
was incubated in the presence of melatonin (30000 nM)
for 30 min. After incubation, the embryos were washed
with phosphate buffer solution (PBS, pH = 7.4), placed in
slides and dried. The slides were exposed to [125I] sensi-
tive film (Kodak insight, Super Poly-Soft 1238054, New
York, USA) for two weeks, and then the film was devel-
oped, fixed (Kodak developer CAT 8610248 and Kodak
Fixer CAT 8610248, New York, USA), rinsed and dried.
The image was captured by scanning (HP Scanjet 2400)
and then analysed using Image J (NIH, Bethesda, MD,
USA).
Immunocytochemistry
The melatonin receptors (MT1 and MT2) and NQO2
enzyme were investigated in oocytes maturated in ab-
sence of the melatonin and day 7 blastocysts. Primary
(NQ02 (N-15): sc-18574; MEL-1B-R (T-18): sc-13177;
MEL-1A-R (R-18): sc-13186) and secondary (Alexa 594-
conjugated anti-goat IgG-CFL 594) antibodies were pur-
chased from Santa Cruz Biotechnology (CA, USA). The
embryos were washed in phosphate buffer saline (PBS),
fixed in 4% paraformaldehyde for 15 min at room
temperature and then rinsed in PBS. Next, embryos were
incubated in 1% bovine serum albumin (BSA) for
15 min at room temperature (blocking) and then incu-
bated with primary antibodies diluted (1:100) in PBS
overnight at 4°C. Embryos were extensively washed in
PBS and then incubated for 45 min at room temperature
with 1:200 of Alexa 594-conjugated anti-goat antibody.
Cell nuclei were stained with 5 μg/ml of Hoechst 33342
in PBS for 15 min at room temperature. Finally, embryos
were mounted on each microscope slide and analyzedon a fluorescence microscope (Nikon Eclipse TE 300,
Nikon Instruments Inc., Tokyo, Japan).
Data analyses
Statistical analyses were done using the BioEstat 5.0 soft-
ware. A value of p < 0.05 was considered to be signifi-




We began by investigating the presence of melatonin
receptors in bovine embryos cultured for 7 days. Data
from autoradiography binding assay showed specific
binding to [125I]-iodomelatonin (17 pM) (Figure 1c) that
was blocked by pre-incubation with 30000 nM mela-
tonin (non-specific binding) (Figure 1b). The total bind-
ing (specific binding plus non-specific binding), is also
showed (Figure 1a).
MT1 and MT2 receptors and NQO2 enzyme
immunocytochemistry in bovine blastocyst
The high affinity melatonin receptor found by autoradi-
ography in blastocysts was investigated by immunocyto-
chemistry. Immunoreactivity neither observed for the
melatonin membrane receptor MT2 nor for the cyto-
solic melatonin binding site NQO2. However, a strong
immunoreactivity was observed for the melatonin recep-
tor MT1 (Figure 2).
Melatonin receptors MT1, MT2 and NQO2 enzyme
immunoreactivity in bovine oocytes
High affinity melatonin membrane receptors and the
NQO2 enzyme were investigated by immunocytochem-
istry in mature oocytes. It was observed immunoreactiv-
ity for MT1, MT2 and NQO2 enzyme. The pattern of
immunoreactivity was different, as showed in the figure
(Figure 3 a, b and c).
Melatonin effects on in vitro bovine embryogenesis
The effects of melatonin (0.1 pM to 1000 nM) on bovine
oocyte IVM and embryo development were analysed at
day 2 (cleavage rate) and at day 7 (blastocyst yields).
Melatonin improved the quality of bovine oocytes mat-
urate in vitro, resulting in an increase in the cleavage
rate and in significant blastocyst formation rate with an
optimum concentration of 1 pM. However, the cleavage
rate of embryos from oocytes treated with melatonin
presented a gradual decline in response to increased
melatonin concentration beyond 1 pM. Similar results
were obtained when melatonin-treated blastocysts devel-
opment was examined. The improvements of melatonin
to blastocyst development decreased in a similar manner
as observed for embryo cleavage over the same
Figure 1 High affinity [125I]-iodomelatonin (17 pM) binding showed by autoradiography in blastocysts. Autoradiograms of the total (a),
non-specific (30000 nM melatonin presence) (b), and specific (c) [125I]-iodomelatonin (17 pM) binding in seven days old bovine embryos that
were produced without melatonin inclusion in oocyte maturation protocol. The autoradiograms are actual size (240 μm, embryo diameter).
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centration to trigger an increase in total cell number
of bovine blastocyst also was 1 pM, however, no inhibi-
tory effects were observed with concentrations up to
1000 nM (data not showed).
Discussion
In this study we showed that a pM concentration range
of melatonin supplementation in IVM medium function-
ally increases cleavage and blastocysts formation rates.
However, while increasing the melatonin concentrationFigure 2 Distribution of the melatonin receptor MT1 in bovine
blastocyst. Immunocytochemistry staining day 7 embryo produced
without melatonin inclusion in oocyte maturation protocol. Positive
staining for MT1 (red) is present throughout the blastocyst. The
embryoblast cells show stronger staining for MT1 than the
trophoblastic cells (Scale bar, 50 μm).up to a μM range, the positive effects of melatonin
decreased in comparison with the values of the control
group. This profile is in accordance with the presence of
the melatonin targets that bind with different affinities
in oocytes, and the most effective concentration range is
related to the MT1 melatonin receptor. In agreement
with this pharmacological profile, MT1, MT2 and
NQO2 immunoreactivity were visualized in oocytes for
the first time in this study. Interestingly, in blastocysts,
the autoradiographic binding assay showed a high affin-
ity site, and immunocytochemistry assays only showed
the presence of the MT1 melatonin receptor. Since the
embryonic genome is activated at the 8-cell stage in
bovine embryos, there is a complete absence of maternal
genetic inheritance in day 7 blastocysts [36]. Thus, this
study shows the novel findings that the MT1 melatonin
receptor is the first to be transcribed in a mammalian
embryo.
Herein, we also showed for the first time the presence
of the cytosolic NQO2 enzyme in oocyte. This detoxify-
ing enzyme is thought to produce free radicals when
activated by xenobiotics, such as menadione and is
inhibited by high concentrations of melatonin [37], as
found in the bovine follicular fluid [15]. Probably its in-
hibition by melatonin takes part in general defense
mechanisms of the oocyte. A recent paper showed a
melatonin protective action against HOCl, preventing
oxidative damage to the metaphase-II oocyte spindle
in vitro, when it was added in IVM medium. This effect
was via the inhibition of the myeloperoxidase enzyme
[8], being more one study showing that melatonin pro-
tection occurs by a myriad of mechanisms.
Despite powerful scavenger actions being considered
the pivotal mechanism underlying melatonin protection
in different cells [9,38], melatonin membrane receptors
are also important as they have a role in spermatozoa
Figure 3 Immunoreactivity patterns of melatonin receptor MT1, MT2 and NQO2 in bovine oocyte. MT1, MT2 melatonin receptors and
NQO2 are expressed by the matured oocyte. The upper-left panel shows localized intense MT1 staining suggesting that MT1 is expressed by
polar bodies. The upper-right panel shows a cluster-like distribution of MT2 throughout the matured oocyte. The bottom-left panel shows a
diffuse expression of NQO2 enzyme, and the bottom-right shows the negative control. (Scale bar, 30 μm).
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shown that the melatonin membrane receptors mRNAs
are present in bovine oocytes as well as bovine cumulus
cells and positively affect cytoplasmic and nuclear mat-
uration [40]. Regarding melatonin mechanism of theTable 1 Embryo production
Group N Cleavage rates (%) Blastocyst yield (%)
Control 75 52.9 ± 2.8 a 30.9 ± 3.9a
0.1 pM 60 57.3 ± 6.6 a 32.0 ± 6.6b
1 pM 75 62.1 ± 5.0 a 43.7 ± 2.3c
0,01nM 75 52.7 ± 1.8 a 34.2 ± 3.6a, b
0,1nM 75 39.4 ± 4.0 b 19.8 ± 3.7a, b
1nM 55 40.4 ± 8.7 b 30.0 ± 3.6b
1 μM 75 34.4 ± 3.5 b 25.5 ± 1.3d
a,b,c,d Values in the same column with different superscripts differ significantly
(P < 0.05). N, total number of oocytes.action, in general, MT1 and MT2 signaling pathways are
not restricted to the Gi protein subunit, resulting in an
inhibition of the adenylate cyclase enzyme. MT1 potenti-
ates phosphoinositide turnover, when it is stimulated by
another receptor, while MT2 can act by coupling with
the Gq protein subunit. This stimulates phosphoinosi-
tide turnover and, by others means, inhibits the guany-
late cyclase enzyme. Therefore, MT1 and MT2 signaling
pathways can induce PKC activation by Ca2+ waves, in
parallel with the inhibition of the cAMP pathways
[41,42].
The mechanism of the oocyte self-maintaining in ar-
rest is poorly understood, however, a review about its
control shows that bovine oocyte maturation is modu-
lated by inhibition of both cAMP and cGMP levels as
well as by the energy sensor AMPK, which is activated
by AMP. In addition, there are studies showing the
importance of the Ca2+ and PKC to bovine oocyte
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cyclase enzyme activity and are able to activate PKC,
which consequently has proven to improve nuclear mat-
uration and the quality of IVP blastocysts. The pM con-
centration range of melatonin observed to affect the
cleavage and blastocysts formation rates is suggestive of
the melatonin action on the MT1 receptor [41]. Interest-
ingly, the MT1 melatonin receptor was characterised by
autoradiography and immunocytochemistry in early day
seven blastocysts, demanding further investigations as to
its constitutive activity at this embryonic age, which will
largely enhance the understanding about melatonin in-
fluence on bovine embryonic development.
Conclusions
Along with the clear immunoreactivity to MT1, MT2
and NQO2 in oocytes, the addition of a melatonin pM
concentration increased cleavage and blastocysts forma-
tion rates. We suggest this is due to the effects of the
MT1 receptor. We suggest that this hormone does not
only have free radical scavenger action, but it also has
effects on oocyte maturation by a myriad of mechan-
isms, including membrane receptor activation.
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